Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Terrascend Corp (TSND.TO)

Terrascend Corp (TSND.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 699,618
  • Shares Outstanding, K 291,507
  • Annual Sales, $ 317,328 K
  • Annual Income, $ -91,101 K
  • 60-Month Beta 2.11
  • Price/Sales 1.53
  • Price/Cash Flow 17.71
  • Price/Book 2.09
Trade TSND.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings $-0.16 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.14 +12.15%
on 04/26/24
2.99 -19.73%
on 04/30/24
-0.42 (-14.89%)
since 04/03/24
3-Month
2.04 +17.65%
on 03/14/24
3.21 -25.23%
on 02/06/24
-0.64 (-21.05%)
since 02/02/24

Most Recent Stories

More News
Stocks in play: TerrAscend Corp.

Today announced the expansion of its Valhalla product offering to include one of the first 100mg edibles ...

TSND.TO : 2.40 (unch)
Stocks in play: TerrAscend Corp.

Announced that it will host a scheduled conference call to discuss the results for its third quarter ...

TSND.TO : 2.40 (unch)
Stocks in play: TerrAscend Corp

Announced the closing of its previously announced acquisition of Herbiculture Inc., a medical dispensary ...

TSND.TO : 2.40 (unch)
Canopy Growth Congratulates TerrAscend on Toronto Stock Exchange Listing

/CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today recognized the successful commencement of trading of...

CGC : 10.24 (-0.97%)
WEED.TO : 13.94 (-1.76%)
TSND.TO : 2.40 (unch)
ATB Capital Markets Inc. is Proud to Sponsor TerrAscend, the First Cannabis Company with Revenues from Multi State Operations in the US to list on the TSX

/PRNewswire/ - Acting as exclusive financial advisor to TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TRSSF), ATB Capital Markets Inc....

TSND.TO : 2.40 (unch)
TRSSF : 1.7200 (unch)
ATB Capital Markets Inc. is Proud to Sponsor TerrAscend, the First Cannabis Company with Revenues from Multi State Operations in the US to list on the TSX

/CNW/ - Acting as exclusive financial advisor to TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TRSSF), ATB Capital Markets Inc. is...

TRSSF : 1.7200 (unch)
TSND.TO : 2.40 (unch)
TerrAscend Corp. Opens the Market

/CNW/ - Jason Wild, Executive Chairman, TerrAscend Corp. (TSX: TSND) ("TerrAscend" or the "Company"), and his team joined Loui Anastasopoulos, Chief Executive...

TSND.TO : 2.40 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation,...

See More

Key Turning Points

3rd Resistance Point 2.54
2nd Resistance Point 2.50
1st Resistance Point 2.45
Last Price 2.40
1st Support Level 2.36
2nd Support Level 2.32
3rd Support Level 2.27

See More

52-Week High 3.21
Fibonacci 61.8% 2.64
Fibonacci 50% 2.47
Last Price 2.40
Fibonacci 38.2% 2.29
52-Week Low 1.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar